Healthcare and Life Sciences

Format: 2017-02-22
Format: 2017-02-22
January 25, 2017 | 65 Pages | SKU: IRTNTR11705

Overview of the global MRSA testing market

The global MRSA testing market is anticipated to grow rapidly and will post a CAGR of more than 11% during the forecast period. The increasing demand for automation and system integration will drive the growth prospects for the global MRSA testing market for the next four years. Since fully automated and semi-automated systems in laboratories enable the doctors to carry out large volumes of tests, the productivity of the health care units improve. Since these systems allow end-users to efficiently handle large test volumes, the results obtained are more accurate and the overall workflow becomes more efficient. For instance, these system's software and graphical user interface (GUI) allow streamlined information management and offer solutions ranging from remote test ordering to sophisticated result analysis.

In terms of geography, the Americas accounted for the maximum market share during 2016 and will continue to dominate the market until the end of 2021. One of the major factors responsible for the market’s growth in the region is the presence of several vendors headquartered in the Americas that provide advanced treatment options. Also, the region is witnessing a high adoption rate of MRSA testing procedure for the diagnosis of various types of infections. Moreover, the market is witnessing an increasing support from the government and private organizations to carry out advanced research activities that involve assays and instruments, which, in turn,  will accelerate the market’s growth in the future.


January 24, 2017 | 68 Pages | SKU: IRTNTR11179

Overview of the global atopic dermatitis drugs market

The global atopic dermatitis drugs market is anticipated to grow at a steady rate and will post a CAGR of more than 4% during the forecast period. The growing prevalence of food allergies exacerbating atopic dermatitis will drive the growth prospects for the global atopic dermatitis drugs market in the forthcoming years. According to the industry research report, almost one-third of the children with atopic dermatitis are diagnosed with food allergy. For instance, according to research studies, 5%-10% of all children have atopic dermatitis, and one-third of them have a food allergy. One of the major factors responsible for the growing risk of severe atopic dermatitis in infancy is related to food sensitization, which is commonly associated with food allergy. It has been observed that these allergies mainly result from the cow’s milk, chicken eggs, peanuts, wheat, soy, nuts, and fish.

The launch of the first biologic for atopic dermatitis will drive the market prospects for the global atopic dermatitis drugs market for the next four years. Biologic agents must have the ability to provide control over the disease when a patient is suffering from moderate to severe atopic dermatitis. It has also been observed that at present, the market players have not been able to provide effective therapeutics to meet the increasing number of unmet needs. However, according to the market research and analysis, patients with atopic dermatitis do not respond to other treatments as they do with biologics, which targets adaptive immune responses


January 23, 2017 | 158 Pages | SKU: IRTNTR11669

Overview of the medical imaging market

Extensive research carried out by the analysts at Technavio has shown that the global medical imaging market will witness steady growth at a moderate CAGR of close to 5% during the forecast period. The growing demand for portable imaging equipment is one of the primary factors driving this market’s growth. Portable imaging equipment offers ease of use and point-of-care applications, which is leading to their increased adoption not only in hospitals but also as a part of homecare. Moreover, there is also an augmented demand for portable devices in the emergency care units for easier and quick usage, faster interventions for acute events, and better monitoring. Owing to the recent advances in technology, vendors are increasingly focussing on incorporating these portable imaging devices with hi-tech features that are at par with the stationary medical imaging equipment. For instance, portable ultrasound devices are equipped the wireless features like Bluetooth, and near-field communication to deliver highly sophisticated home-based healthcare service for individuals. Similarly, portable X-ray systems are lightweight and convenient to use as the X-ray images can be sent from anywhere in the hospital, saving a lot of time.

In terms of geography, the Americas dominated the global medical imaging market during 2016 and will continue to lead the market over the next four years. The medical imaging market in the Americas is largely dominated by the US owing to the better infrastructure and awareness about


January 20, 2017 | 83 Pages | SKU: IRTNTR11491

Overview of the global neurology endoscopy devices market

Technavio’s market research analyst predicts the global neurology endoscopy devices market to grow at a CAGR of over 7% between 2017 and 2021. This market is witnessing the emergence of several neurosurgery technologies, which will modify the delivery paradigm of surgical deliveries. Several manufacturers in the market are also adopting robotic-assisted surgeries to enhance the precision and efficacy. Also, many neuro specialty hospitals are incorporating their operating rooms with neurology endoscopy devices, which aids in performing accurate brain or neurological surgeries. Moreover, the introduction of 3D imaging in endoscopes has not only enhanced the visibility aspects but also has led to the better perception and evaluation of the nerve damage. One of the latest developments in the market is the integration of neurology endoscopes with the surgical devices. Neurology endoscopes are integrated with surgical devices to improve the efficiency of surgeries. Foer instance, NICO came up with the NICO Myriad system, which is an automated disposable resection device that is used during neurology endoscopy. The resection device is used for the resection of craniopharyngiomas, pituitary tumors, colloid cysts, and other neurosurgical disorders.

In terms of geography, the Americas led the global market for neurology endoscopy devices and will continue to maintain its dominance over the forecast period. The US is the major revenue contributing country in the region owing to the availability of better healthcare facilities, surging implementation of


January 20, 2017 | 77 Pages | SKU: IRTNTR11658

Overview of the bio-absorbable stents market

Extensive research carried out by the analysts at Technavio has shown that the global bio-absorbable stents market will witness impressive growth and post a staggering CAGR of close to 41% during the forecast period. The augmented demand for minimally invasive (MI) surgical procedures is one of the primary factors driving this market’s growth. As MI endovascular procedures are performed with minute incisions in the body, it is increasingly being used to treat aortic aneurysm, stenosis, and plaque in the blood vessels of the heart and other vessel walls of peripheral organs. Also, MI procedures offer faster recovery, lesser pain and chances of infection, reduced hospital stay and chances of post-surgical complications. As a result, an increasing number of surgeons prefer MI methods as a procedure for vascular stent implantation. The growing number of patients with cardiovascular diseases (CVDs) like abdominal aortic aneurysm will boost the demand for bio-absorbable stents in the coming years.

In terms of geographical regions, the Americas was the highest revenue contributing region in the global bio-absorbable stents market during 2016 and will continue to lead the market in the coming years. The US accounted for the highest market shares in the region. The increasing adoption of technologically advanced products, as well as the increase in the number of coronary and peripheral procedures in the US,  will contribute to the growth of this market in the


January 20, 2017 | 101 Pages | SKU: IRTNTR11654

Overview of the critical care therapeutics market

According to the market research analysts at Technavio, the critical care therapeutics market is expected to witness steady growth and post a CAGR of close to 4% during the predicted period. With the increasing number of joint replacement and cardiovascular surgical procedures, the market for critical care therapeutics is expected to have a positive outlook in the coming years. Surgical procedures such as hip and knee replacements result in long periods of immobility, which considerably increases the chances of developing deep vein thrombosis (DVT) due to reduced blood flow. For instance, according to the CDC 2015 report, around 719,000 knee replacement surgeries and 332,000 hip replacement surgeries are performed in the US every year. Moreover, the increasing number of cardiovascular procedures like stent grafts and coronary artery bypass grafting will help boost the demand for critical care therapeutics over the next four years.

In terms of geography, the Americas was the highest revenue contributor in the market during 2016 and will continue to lead the market during the forecast period. The growth of this market in the Americas is attributed to the introduction of Kcentra, the first four-factor prothrombin complex concentrate and Tretten, the first recombinant factor XIII concentrate in 2013. The increasing uptake of these products during the forecast period will have a positive impact on the market. Moreover, the favorable healthcare reforms of various countries in the Americas will also contribute to this market’s growth in the region.

Competitive landscape and key vendors

The global critical


Pages